◄ back to all posts
Financial data and stock pages provided by
Fintel.io
◄ back to all posts
JNJ: Johnson & Johnson Stock
Written by | Jul 6, 2018
SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 453,418.12 |
| Enterprise Value ($M) | 469,396.12 |
| Book Value ($M) | 69,580.00 |
| Book Value / Share | 26.42 |
| Price / Book | 6.52 |
| NCAV ($M) | -53,091.00 |
| NCAV / Share | -20.16 |
| Price / NCAV | -8.54 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.15 |
| Return on Assets (ROA) | 0.09 |
| Return on Equity (ROE) | 0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.13 |
| Current Ratio | 1.39 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 53,769.00 |
| Assets | 176,440.00 |
| Liabilities | 106,860.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | n/a |
| Net Income | 14,714.00 |
| Earnings Per Share Diluted | 5.51 |
| Earnings Per Share Basic | 5.59 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 23,536.00 |
| Cash from Investing | -20,825.00 |
| Cash from Financing | -20,825.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 5.47 | -5.16 | |
| 13G/A | Vanguard Group Inc | 8.66 | -0.15 | |
| 13G/A | BlackRock Inc. | 7.20 | -2.36 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K | ||
| Quarterly Report – 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 345,917 | 5,346,340 | 6.47 | |
| 410,995 | 4,206,501 | 9.77 | |
| 698,713 | 5,750,650 | 12.15 | |
| 631,110 | 6,919,217 | 9.12 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| ELAT – Elanco Animal Health Incorporated 5.00% Tangible Equity Units | GSK – GlaxoSmithKline plc |
| HEXO – HEXO Corp. | LCI – Lannett Company, Inc. |
| LLY – Eli Lilly And Co |
Financial data and stock pages provided by
Fintel.io
2018/07/06
